Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-018-0658-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

British Journal of Haematology
Hematology
2010English

Dose Proportionality and Pharmacokinetics Of carvedilol Sustained-Release Formulation: A single Dose-Ascending 10-Sequence Incomplete Block Study

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-In-Human Study of a Novel Antimalarial Drug

Malaria Research and Treatment
EpidemiologyInfectious Diseases
2014English

Multiple-Dose Pharmacokinetics of Amdinocillin in Healthy Volunteers

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

Multiple-Dose Pharmacokinetics of Amdinocillin in Healthy Volunteers.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

KVD900 as a Single Dose, Rapid, Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema Attacks: Pharmacokinetic and Pharmacodynamic Results From a Phase 1 Single Ascending Dose Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2018English

The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study

Clinical Cancer Research
Cancer ResearchOncology
2006English

Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-Fgf23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia

Journal of Clinical Pharmacology
Pharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy